COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 422: Articles 4211-4220  | Next

Coronaviruses Spike glycoprotein endodomains: the sequence and structure-based comprehensive study
Kumar, P., Bhardwaj, A., Mukherjee, B., Joshi, R., Giri, R.
10.1101/2023.08.16.553512 — Posted: 2023-08-16
Predicting host-based, synthetic lethal antiviral targets from omics data
Staheli, J. P., Neal, M. L., Navare, A., Mast, F. D., Aitchison, J. D.
10.1101/2023.08.15.553430 — Posted: 2023-08-16
Novel risk loci for COVID-19 hospitalization among admixed American populations
Carracedo, A., Spanish COalition to Unlock Research on host GEnetics on COVID-19 (SCOURGE)
10.1101/2023.08.11.23293871 — Posted: 2023-08-15
"Getting pregnant during the COVID 19 was a big risk because getting the help from the clinic was not easy": COVID-19 experiences of women and healthcare providers in Harare, Zimbabwe.
Mupambireyi, Z., Cowan, F., Chappell, E., Chimwaza, A., Manika, N., Wedderburn, C. J., Gannon, H. J., Gibb, T., Heys, M. J., Fitzgerald, F. J., Chimhuya, S., Gibb, D. M., Ford, D. J., Mushavi, A., Bwakura-Dangarembizi, M.
10.1101/2023.08.11.23293472 — Posted: 2023-08-15
Individual level analysis of digital proximity tracing for COVID-19 in Belgium highlights major bottlenecks
Geenen, C., Raymenants, J., Gorissen, S., Thibaut, J., McVernon, J., Lorent, N., Andre, E.
10.1101/2023.08.11.23293971 — Posted: 2023-08-15
Published benefits of ivermectin use in Itajai, Brazil for COVID-19 infection, hospitalisation, and mortality are entirely explained by statistical artefacts
Mills, R., Pecanha Antonio, A. C., Tucker-Kellogg, G.
10.1101/2023.08.10.23293924 — Posted: 2023-08-15
A Single-Tube Colorimetric Loop-Mediated Isothermal Amplification for Rapid Detection of SARS-CoV-2 RNA
Hongjaisee, S., Kham-Kjing, N., Musikul, P., Daengkaokhew, W., Kongson, N., Guntala, R., Jaiyapan, N., Kline, E. C., Panpradist, N., Ngo-Giang-Huong, N., Khamduang, W.
10.1101/2023.08.10.23293869 — Posted: 2023-08-15
A Susceptible Vaccinated Exposed Infected Hospitalised and Removed/Recovered (SVEIHR) Model Framework for COVID-19
Oyamakin, O. S., Popoola, J. I.
10.1101/2023.08.10.23293942 — Posted: 2023-08-15
Effect of vaccination certification with mass vaccination and non-pharmaceutical interventions on mitigating COVID-19
Cao, H., Cao, L.
10.1101/2023.08.10.23293925 — Posted: 2023-08-15
Digital Mental Health Service engagement changes during Covid-19 in children and young people across the UK: presenting concerns, service activity, and access by gender, ethnicity, and deprivation
Knipe, D., de Ossorno Garcia, S., Salhi, L., Mainstone-Cotton, L., Sefi, A., John, A.
10.1101/2023.08.11.23293977 — Posted: 2023-08-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).